Biosource International Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biosource International

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rich Powers who wrote (502)	7/7/1998 2:08:00 PM
From: Joe Dancy	Read Replies (2) of 696

Listened to internet presentation today. Was really neat and well done by both the company and the Wall Street Forum. Did not say anything we did not already know, but here is my two paragraph summary FWIW: *************************** BIOSOURCE INTERNATIONAL (BIOI) The company made a presentation to analysts at a Wall Street Forum conference carried over the Internet on June 22nd. The CEO noted that the company provides research and diagnostic tools to the biotechnology sector - and that AIDS, cancer, and related research would drive growth of this sector of the biotech market upward at a 20% annual rate for the foreseeable future. BIOI developed 246 products internally last year and will exceed that number this year, and now sells over 17,000 research related products. It has an international distribution network for its products, and faces minimal regulatory hurdles in getting the research products approved for sale. The company expects revenues to continue to grow strongly this year, has a "very aggressive" share buyback program in place and plans to continue to repurchase shares, and has a strong balance sheet with lots of cash available for the repurchase program. Joe

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next